venBio Partners is a healthcare-focused investment firm that provides venture capital to life-sciences companies, particularly biotechnology and biopharmaceutical businesses. It serves founders and management teams seeking capital and strategic support to develop medicines and related healthcare products.
Subscribe to see venBio Partners’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
venBio Partners is a company headquartered in United States. Xcout tracks 8 named people at venBio Partners, including David Pezeshki (Chief Financial Officer).
2 more named people on record for venBio Partners, with roles, board committees and tenure — see the full roster →
A few of venBio Partners's closest competitors — see the full list of competitors and alternatives →
Oxford Bioscience Partners is a venture capital firm focused on investing in early-stage life sciences and biotechnology companies. It provides capital and support to entrepreneurs developing therapeutics, diagnostics, and related healthcare technologies.
LifeSci Venture Partners is a venture capital firm that invests in clinical-stage healthcare and life sciences companies. The firm provides collaborative financial capital, strategic support, and access to a global healthcare consultancy platform to accelerate medical breakthroughs and business development for entrepreneurs and scientists.
Pivotal bioVenture Partners is a life-sciences venture capital firm that invests in biotechnology and biopharmaceutical companies, particularly those developing novel therapeutics. It provides funding and strategic support to early- and growth-stage companies in the biomedical sector.
Vensana Capital is an investment firm focused on healthcare, including medical technology, life sciences, healthcare services, and related technologies. It provides venture and growth capital to companies developing products and services intended to improve healthcare delivery and outcomes.
4BIO Capital is a specialist venture capital firm investing in early-stage life-sciences and biotechnology companies, particularly those developing advanced therapies such as cell and gene therapies, RNA medicines, and related technologies. It provides funding and strategic support to entrepreneurs and companies developing innovative therapeutics.
3E Bioventures Capital is a venture capital firm focused on life sciences and healthcare. It provides investment capital to entrepreneurs and companies developing biotechnology, medical technology, diagnostics, and related healthcare innovations.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about venBio Partners? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.